topic about cancer diagnostics or therapeutics, with therapeutics to include any type of treatment (e.g., drug, device, etc.)
[Insight: One of the more fascinating aspects of medical technology development is the penchant in the industry for finding different ways to accomplish traditional tasks in medical and surgical care. While certainly some technologies can be oversold for their putative clinical benefits --- driving up healthcare costs and giving the industry a bad rap --- [...]
Technologies for ablation and other energy-based treatments in medical/surgical markets are currently dominated by electrosurgical-type therapies, but a growing array of other modalities are creating new applications or penetrating existing ones. These modalities include hydromechanical, microwave, thermal, cryotherapy, ultrasound, radiofrequency (RF), light, radiation (radiosurgery, radiotherapy) and electrical.
At right is shown the forecast, by modality type, [...]
The medical markets inthe Asia/Pacific region show enormous variations in size, due to differences in healthcare expenditure as well as the obvious differing population sizes. Although China and India have vastly greater populations than other countries in the region, it is the Japanese ablation market that takes the largest share of the global market, [...]
Below is a recent MedMarket Diligence report on Ablation Technologies. The report is described in detail at link.
Ablation Technologies Worldwide Market, 2008-2017: Products, Technologies, Markets, Companies and Opportunities
· 264 pages · 70 Exhibits · 61 Company Profiles · September 2008 · Report #A125
This report is a [...]
Below is Cleveland Clinic’s list of the top ten medical innnovations for their potential impact on patient care in the coming year. (I’ll add my two cents afterward.)
Use of circulating tumor cell technology. Improves adjustments to cancer treatment, particularly for patients with repeat cancer
Warm organ perfusion device. Increases from 4 to 12 [...]
The surgical ablation of soft tissues will see significant growth in the next few years and, among them, radiofrequency will demonstrate some of the most significant growth. Other modalities include hydromechanical, microwave, thermal, cryotherapy, ultrasound, light, radiation and electrical. Growth in these ablation segments in the U.S. is shown in the chart below.
Source: MedMarket Diligence [...]
The major national markets in Western Europe for ablation technologies account for almost 12% of the global ablation market. Their share of the total medical device market is around 30%. Healthcare spending per capita is broadly similar across all the countries for which an example forecast (France) is provided below, ranging from approximately [...]
Excerpt from “Worldwide Ablation Technologies”, report #A125 from MedMarket Diligence.
An estimated one third of men older than 50 years develop symptoms of prostate enlargement, and 30% of these men eventually require surgery. Some 50% of men have histologic evidence of BPH by the age of 50 years, which increases to 75% in men older than [...]
The energy-based medical device industry is led by a diverse group of companies, including small-to-medium pure-play companies specializing in ablation therapies and large multinationals whose interests encompass other classes of medical devices as well as ablation products. Key companies include Medtronic, St. Jude Medical, Varian Medical Systems, Boston Scientific (including Guidant), and Getinge.
In terms of [...]
From Report #A125, “Ablation Technologies Worldwide, 2008-2017″, published September 2008. See link.
Below are selected radiofrequency ablation products, their applications and their status of regulatory approval.
[Table=11]
For additional information on Report #A125, see link. The report may be purchased online or via Google Checkout, below.
USD3,450.00 - Worldwide Ablation Technologies, 2008-2017 (PDF) USD3,450.00 - Worldwide [...]